Several members of the Emergency Committee expert panel that advised the World Health Organization (WHO) during the swine flu pandemic have come forward admitting connections to the drug industry. A recent report revealed that five of the fifteen members on the panel had received some type of financial support from pharmaceutical companies either during or prior to the pandemic.
The panel was composed of members from almost every continent, and many were scientists and researchers. An entire list of panel members can be viewed here.
During the outbreak, WHO had concealed the names of these members to allegedly protect them from public pressure, but WHO denies allegations that panel member connections to drug companies were conflicts of interests.